Emmi, Nestle, Petroplus, Santhera, Sonova: Swiss Equity Preview

The following is a list of companies whose shares may have unusual price changes in Zurich. Stock symbols are in parentheses after company names. Share prices are from the last close.

The Swiss Market Index of the biggest and most actively traded companies fell less than 0.1 percent to 6,553.67 yesterday. The broader Swiss Performance Index also slipped less than 0.1 percent.

Emmi AG (EMMN SW): The dairy company reported full-year sales of 2.68 billion Swiss francs ($2.85 billion) compared with 2.62 billion francs a year earlier. The shares rallied 4.1 percent to 216 francs.

Nestle SA (NESN VX): The world’s biggest food company said it temporarily suspended Herta halal supplies. Separately, the Vevey, Switzerland-based company said it will invest 505 million rand ($71 million) in South Africa. Investments include a plant to produce its Milo and Cheerio cereal brands and a noodle- producing factory. Nestle rose 0.4 percent to 51.85 francs.

Petroplus Holding AG (PPHN VX): Europe’s biggest independent oil refiner reported an estimated “clean” net income of $65 million for the fourth quarter, compared with a loss of $150 million a year earlier. The shares slipped 0.3 percent to 15.99 francs.

Santhera Pharmaceuticals Holding AG (SANN SW): The Swiss drug discovery and development company said it ended talks with Newron Pharmaceuticals SpA, the Italian drugmaker developing a Parkinson’s disease treatment with Merck KGaA. Newron was in negotiations to sell itself to Santhera, a person with knowledge of the situation said last month. The share rose 1.3 percent to 8.80 francs.

Sonova Holding AG (SOON VX): The Staefa, Switzerland-based company expects its HiRes90K hearing implants, which it recalled in November after two patients complained about severe pain, to be back on the market in April, Handelszeitung said, citing an interview with Chief Executive Officer Valentin Chapero Rueda. The shares added 0.2 percent to 118.60 francs.

To contact the reporter on this story: Giles Broom in Zurich at gbroom@bloomberg.net.

To contact the editor responsible for this story: David Merritt at dmerritt1@bloomberg.net.

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.